Synapse - Owen O'connor

Search Within

Owen O'connor

Results (98)

Pralatrexate: An emerging new agent with activity in T-cell lymphomas

Journal Article

O'Connor, O. A.
Current Opinion in Oncology (2006)

Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma

Journal Article

O'Connor, O. A.
British Journal of Cancer (2006)

Fulltext@MSK | Save

Novel small molecules in the treatment of lymphomas

Journal Article

Gerecitano, J.; O'Connor, O. A.
Cancer Treatment and Research (2006)

Fulltext@MSK | Save

Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: A possible surrogate marker of response?

Journal Article

Gerecitano, J.; Goy, A.; Wright, J.; Macgregor-Cortelli, B.; Neylon, E.; Gonen, M.; Esseltine, D.; Boral, A.; Schenkein, D.; Busam, K.; more...
British Journal of Haematology (2006)

Fulltext@MSK | Save

Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy

Meeting Abstract

Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O.
Blood (2005)

Fulltext@MSK | Save

Targeting the proteasome pathway with bortezomib in patients with mantle cell (MCL) and follicular lymphoma (FL) produces prolonged progression free survival among responding patients: Results of a multicenter phase II experience

Meeting Abstract

O'connor, O.; Wright, J.; Moskowitz, C.; Straus, D.; Portlock, C.; Hamlin, P.; Neylon, E.; Evans, A.; Winter, J.; Gordon, L.; more...
Annals of Oncology (2005)

Fulltext@MSK | Save

Targeting the microtubule apparatus in indolent and mantle cell lymphoma with the novel epothilone anlog BMS 247550 induces major and durable remissions in very drug resistant disease

Meeting Abstract

O'connor, O.; Straus, D.; Moskowitz, C.; Hamlin, P.; Portlock, C.; Gerecitano, J.; Neylon, E.; Colevas, D.; Zelenetz, A.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Oral administration of the opium alkaloid noscapine (NOS) exhibits potent anti-tumor activity against non-Hodgkin's lymphomas and myeloma cell lines in vitro and in vivo in SCID-beige murine xenograft models

Meeting Abstract

O'connor, O.; Mastrella, J.; Smith, E.; Toner, L.; Auerbach, A.; Leonard, J. P.
Blood (2005)

Fulltext@MSK | Save

Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity

Meeting Abstract

O'connor, O.; Hamlin, P. A.; Neylon, E.; Moskowitz, C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Cortelli, B.; Zelenetz, A. D.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat

Meeting Abstract

Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
Blood (2005)

Fulltext@MSK | Save